IPOsBy The Online Investor Staff, updated Sat., Mar. 28, 4:53 PM
|This Slide: #1 of 15|
Slide #1. IMARA Inc. — Initial Public Offering
Price Per Share:
IMARA Inc. (the "Company") (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, known as hemoglobinopathies, announced the pricing of its initial public offering of 4,700,000 shares of common stock at a public offering price of $16.00 per share, for gross proceeds of $75.2 million, before underwriting discounts and commissions and offering expenses payable by the Company. The offering is expected to close on March 16, 2020, subject to customary closing conditions. In addition, the Company has granted the underwriters an option for a period of 30 days to purchase up to 705,000 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions. All shares are being offered by the Company.